File:Screenshot 2021-07-11 at 14-04-04 Safety and Efficacy of Single-Dose Ad26 COV2 S Vaccine against Covid-19 NEJM.png
Original file (783 × 1,024 pixels, file size: 223 KB, MIME type: image/png)
Summary
https://www.nejm.org/doi/full/10.1056/NEJMoa2101544
Figure 2. Cumulative Incidence of Covid-19 with Onset at Least 1 Day after Vaccination and Vaccine Efficacy over Time.
Panel A shows the cumulative incidence of moderate to severe–critical cases of coronavirus disease 2019 (Covid-19); circles indicate severe–critical cases. Panel B shows the cumulative incidence of severe–critical cases. Cases included in the analyses in Panels A and B were centrally confirmed cases in the full analysis set among participants who were seronegative at baseline. Panel C shows the cumulative incidence of severe–critical cases in South Africa among participants who were seronegative at baseline; these cases were those that were positive on reverse-transcriptase–polymerase-chain-reaction (RT-PCR) testing from all sources, whether centrally confirmed or not.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 13:05, 11 July 2021 | | 783 × 1,024 (223 KB) | Joosteto (talk | contribs) | https://www.nejm.org/doi/full/10.1056/NEJMoa2101544 Figure 2. Cumulative Incidence of Covid-19 with Onset at Least 1 Day after Vaccination and Vaccine Efficacy over Time. Panel A shows the cumulative incidence of moderate to severe–critical cases o... |
You cannot overwrite this file.
File usage
The following page uses this file:
